drugset / Trial / NCT02802059

E. Coli Nissle 1917 - Suspension for Infection Prophylaxis

NCT02802059 ↗

RandomizedParallel-groupDouble-blindPrevention

Summary

This study evaluates the long term effects of E. coli strain Nissle 1917 (EcN-Suspension) probiotic bacteria administration on the number of both, bacterial and viral infections during the first 24 months of infant's life. Half of study participants will receive EcN-Suspension, while the other half will receive placebo. In an additional non-clinical explorative evaluation will furthermore be investigated whether the early intestinal colonization with E.coli strain Nissle 1917 affects the establishment of the intestinal microbiota.

Timeline

Start
2015-10-07
Primary completion
2020-10-12
Completion
2020-10-12

Drugs

EvaluationDrugModalityDoseRoute
Subject E. coli strain Nissle 1917 Other / unclassified 1 ml —

Indications